The university's biosafety manager Rebecca Moritz says Yoshihiro Kawaoka is testing potential drug therapies for the virus. Moritz says not a lot is known about the virus.
The State Journal (http://bit.ly/1rjYOrK ) reports Kawaoka is doing the research if labs that are classified with biosafety levels of two and three, which require some precautions.
The National Institutes of Health in 2006 told Kawaoka his Ebola research needed to be done in a level four lab, the highest level. Since the university didn't have such a lab, Kawaoka stopped his research. In 2010, the NIH reversed its decision and said the work could be done in a level two lab.